Empagliflozin and Hepatic Glucose Metabolism

Completed · Phase 4 · Has a placebo group

Conditions studied: Hepatic Glucose Metabolism

In brief

the aim of this study is to examine the role of autonomic nervous system in the increase in hepatic glucose production in response to glucosuria caused by inhibition of renal glucose uptake

Key facts

Study ID

NCT03193684

Run by

The University of Texas Health Science Center at San Antonio

People needed

72

Starts

2018-05-20

Expected to finish

2024-01-30

Last updated by the study team

2024-08-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• eGFR>60 ml/min healthy volunteers type 2 diabetes patients who otherwise healthy

You may not qualify if…

• eGFR <60 T2DM patients on insulin, GLP-1 RA or SGLT2 treatment Major organ disease type 1 diabetes

Where it is running

• Diabetes Division, UTHSCSA — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.